-logo.jpg "AmerisourceBergen logo")
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNYSE:ABC
Previous Symbol
CUSIP03073E10
Phone610-727-7000
Debt
Debt-to-Equity Ratio1.36
Current Ratio0.93
Quick Ratio0.50
Price-To-Earnings
Trailing P/E Ratio13.69
Forward P/E Ratio13.05
P/E Growth1.32
Sales & Book Value
Annual Sales$167.94 billion
Price / Sales0.11
Cash Flow$9.0499 per share
Price / Cash9.82
Book Value$14.10 per share
Price / Book6.30
Profitability
EPS (Most Recent Fiscal Year)$6.49
Net Income$1.66 billion
Net Margins0.99%
Return on Equity45.54%
Return on Assets3.80%
Miscellaneous
Employees20,000
Outstanding Shares216,360,000
Market Cap$19.20 billion
OptionableOptionable
AmerisourceBergen (NYSE:ABC) Frequently Asked Questions
What is AmerisourceBergen's stock symbol?
AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."
How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?
AmerisourceBergen declared a quarterly dividend on Tuesday, November 6th. Shareholders of record on Monday, November 19th will be given a dividend of $0.40 per share on Monday, December 3rd. This represents a $1.60 annualized dividend and a yield of 1.80%. The ex-dividend date is Friday, November 16th. This is a boost from AmerisourceBergen's previous quarterly dividend of $0.38. View AmerisourceBergen's Dividend History.
How were AmerisourceBergen's earnings last quarter?
AmerisourceBergen Corp. (NYSE:ABC) issued its quarterly earnings results on Tuesday, November, 6th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.44 by $0.01. The company earned $43.30 billion during the quarter, compared to analyst estimates of $43.27 billion. AmerisourceBergen had a net margin of 0.99% and a return on equity of 45.54%. The company's quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.33 EPS. View AmerisourceBergen's Earnings History.
When is AmerisourceBergen's next earnings date?
What guidance has AmerisourceBergen issued on next quarter's earnings?
AmerisourceBergen updated its FY19 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of $6.65-6.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.13. AmerisourceBergen also updated its FY 2019 guidance to $6.65-6.95 EPS.
What price target have analysts set for ABC?
15 brokers have issued 12-month price objectives for AmerisourceBergen's shares. Their forecasts range from $88.00 to $115.00. On average, they anticipate AmerisourceBergen's stock price to reach $100.9286 in the next twelve months. This suggests a possible upside of 13.6% from the stock's current price. View Analyst Price Targets for AmerisourceBergen.
What is the consensus analysts' recommendation for AmerisourceBergen?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AmerisourceBergen.
Has AmerisourceBergen been receiving favorable news coverage?
Headlines about ABC stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. AmerisourceBergen earned a news sentiment score of 1.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near future.
Who are some of AmerisourceBergen's key competitors?
Who are AmerisourceBergen's key executives?
AmerisourceBergen's management team includes the folowing people:
- Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
- Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
- Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
- Mr. James D. Frary, Exec. Officer (Age 46)
- Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
Who are AmerisourceBergen's major shareholders?
AmerisourceBergen's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.16%), JPMorgan Chase & Co. (3.22%), FMR LLC (2.21%), Franklin Resources Inc. (1.75%), FIL Ltd (1.43%) and Baupost Group LLC MA (1.27%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.
Which major investors are selling AmerisourceBergen stock?
ABC stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Janus Henderson Group PLC, Wells Fargo & Company MN, Los Angeles Capital Management & Equity Research Inc., Unigestion Holding SA, PointState Capital LP, Mitsubishi UFJ Trust & Banking Corp and Tavio Capital LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.
Which major investors are buying AmerisourceBergen stock?
ABC stock was purchased by a variety of institutional investors in the last quarter, including Baupost Group LLC MA, Baupost Group LLC MA, Equity Investment Corp, BlackRock Inc., Ceredex Value Advisors LLC, Victory Capital Management Inc., FMR LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for AmerisourceBergen.
How do I buy shares of AmerisourceBergen?
Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AmerisourceBergen's stock price today?
One share of ABC stock can currently be purchased for approximately $88.87.
How big of a company is AmerisourceBergen?
AmerisourceBergen has a market capitalization of $19.20 billion and generates $167.94 billion in revenue each year. The company earns $1.66 billion in net income (profit) each year or $6.49 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.
What is AmerisourceBergen's official website?
How can I contact AmerisourceBergen?
AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]sourcebergen.com.
MarketBeat Community Rating for AmerisourceBergen (NYSE ABC)
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
